Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 2 Recurrence 2 Osteosarcoma 2 Sarcoma, Kaposi 1 Rhabdomyosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Glioma 1 GIST 1 Central Nervous System Neoplasms 1 Bone Neoplasms 1

Interventions

vandetanib 1 pazopanib 1 olverembatinib 1 lenvatinib 1 avapritinib 1 Surgical Procedures, Operative 1 Imatinib Mesylate 1 Coal Tar 1 6-chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-ylamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

GIST × lenvatinib × Sarcoma × Clear all

NCT07096609 2026-04-03

LONGIST

Asan Medical Center

Phase 1/2 Recruiting

GIST

Data powered by HemOnc (CC BY 4.0) Colophon ⚡